Francesco Crescenzo
Overview
Explore the profile of Francesco Crescenzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crescenzo F, Danese A, DallOra F, Turazzini M
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076907
Chronic graft-versus-host disease (cGVHD) is a prognostically negative event following hematopoietic stem cell transplant (HSCT). While cGVHD mainly affects the muscles, skin, oral mucosa, eyes, lungs, gastrointestinal tract, and liver,...
2.
Ziccardi S, Crescenzo F, Guandalini M, Caliskan G, Martinelli L, Tamanti A, et al.
Brain Commun
. 2024 Nov;
6(6):fcae355.
PMID: 39494361
Despite grey matter atrophy in cortical and subcortical regions has been related to cognitive impairment in multiple sclerosis, only a few studies evaluated its predictive value for alterations in the...
3.
Mazziotti V, Crescenzo F, Turano E, Guandalini M, Bertolazzo M, Ziccardi S, et al.
J Neuroinflammation
. 2024 Aug;
21(1):209.
PMID: 39169320
Tumor necrosis factor (TNF) is a pleiotropic cytokine regulating many physiological and pathological immune-mediated processes. Specifically, it has been recognized as an essential pro-inflammatory cytokine implicated in multiple sclerosis (MS)...
4.
Marastoni D, Foschi M, Eccher C, Crescenzo F, Mazziotti V, Tamanti A, et al.
Front Immunol
. 2024 Feb;
15:1343892.
PMID: 38404586
Background: Cladribine has been introduced as a high-efficacy drug for treating relapsing-remitting multiple sclerosis (RRMS). Initial cohort studies showed early disease activity in the first year after drug initiation. Biomarkers...
5.
Ziccardi S, Pisani A, Schiavi G, Guandalini M, Crescenzo F, Colombi A, et al.
Eur J Neurol
. 2023 Jan;
30(5):1378-1388.
PMID: 36692863
Background And Purpose: Although cognitive impairment (CI) is frequent in multiple sclerosis (MS) patients, few studies (and with conflicting results) have evaluated early predictors of CI in the long term....
6.
Mazziotti V, Crescenzo F, Tamanti A, Dapor C, Ziccardi S, Guandalini M, et al.
Biomedicines
. 2022 Dec;
10(12).
PMID: 36551795
The impact of disease-modifying therapies (DMTs) on the immune response to coronavirus disease-2019 (COVID-19) vaccines in persons with multiple sclerosis (pwMS) needs further elucidation. We investigated BNT162b2 mRNA COVID-19 vaccine...
7.
Crescenzo F, Del Colle R, Ajena D, Stecca M, Ferigo L, Rossi F, et al.
BMC Neurol
. 2022 Nov;
22(1):444.
PMID: 36443684
Background: Food-borne botulism is a rare neuromuscular junction disorder due to the effect of toxins released from Clostridium botulinum ingested by eating improperly stored food. Its classic manifestation is a...
8.
Marastoni D, Crescenzo F, Pisani A, Zuco C, Schiavi G, Benedetti G, et al.
Mult Scler
. 2022 Jun;
28(13):2090-2098.
PMID: 35765211
Background: Data on the effect of dimethyl fumarate (DMF) on focal and diffuse gray matter (GM) damage, a relevant pathological substrate of multiple sclerosis (MS)-related disability are lacking. Objective: To...
9.
Marastoni D, Pisani A, Schiavi G, Mazziotti V, Castellaro M, Tamanti A, et al.
Ther Adv Neurol Disord
. 2022 Jun;
15:17562864221092124.
PMID: 35755969
Background: Disease activity in the first years after a diagnosis of relapsing-remitting multiple sclerosis (RRMS) is a negative prognostic factor for long-term disability. Markers of both clinical and radiological responses...
10.
Ziccardi S, Crescenzo F, Calabrese M
Diagnostics (Basel)
. 2022 Jan;
12(1).
PMID: 35054216
Social cognition deficits have been described in people with multiple sclerosis (PwMS), even in absence of a global cognitive impairment, affecting predominantly the ability to adequately process emotions from human...